Changes in lung function after surgery for mesothelioma

Asian Cardiovascular and Thoracic Annals

Volumn 21, Issue 1, 2013, Pages 48-55

  Ploenes, Till ^a   Osei Agyemang, Thomas ^a   Krohn, Alexander ^a   Waller, Cornelius F ^a   Duncker Rohr, Viola ^a   Elze, Mirjam ^a   Passlick, Bernward ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

EPP; Extrapleural pneumonectomy; Length of stay; MPM; P D, pleurectomy decortication; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; DECORTICATION; EXTRAPLEURAL PLEUROPNEUMONECTOMY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; TOTAL LUNG CAPACITY; VITAL CAPACITY;

AGED; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TIME FACTORS; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84877835448     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492312454017     Document Type: Article

References (24)

1. Wagner JC, Sleggs CA and Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260-271.
2. Merritt N, Blewett CJ, Miller JD, Bennett WF, Young JE and Urschel JD. Survival after conservative (palliative) management of pleural malignant mesothelioma. Surg Oncol 2001; 78: 171-174.
3. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135: 620-626.
4. Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011; 12: 763-772.
5. Rice D, Rusch V, Pass H, Asamura H, Nakano T, Edwards J, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 2011; 6: 1304-1312.
6. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001; 122: 788-975.
7. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54-63.
8. Ribak J, Lilis R, Suzuki Y, Penner L and Selikoff IJ. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988; 45: 182-187.
9. Lee JH, Song EM, Sim YS, Ryu YJ and Chang JH. Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol 2011; 6: 305-309.
10. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, et al. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer 1996; 78: 1314-1319.
11. Sensakovic WF, Armato 3rd SG, Starkey A, Kindler HL and Vigneswaran WT. Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication. Acad Radiol 2011; 18: 294-298.
12. Rzyman W, Skokowski J, Romanowicz G, Lass P and Dziadziuszko R. Decortication in chronic pleural empyema - effect on lung function. Eur J Cardiothorac Surg 2002; 21: 502-507.
13. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 1996; 14: 1-12.
14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
16. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
17. Ribi K, Bernhard J, Schuller JC, Weder W, Bodis S, Jörger M, et al. Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer 2008; 61: 398-404.
18. Cao CQ, Yan TD, Bannon PG and McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010; 5: 1692-1703.
19. Bolukbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A and Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2011; 71: 75-81.
20. Neragi-Miandoab S, Weiner S and Sugarbaker DJ. Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg 2008; 7: 1039-1042.
21. Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR, et al. Phase I to II study of pleurectomy/ decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006; 24: 1561-1567.
22. Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128: 138-146.
23. Sharif S, Zahid I, Routledge T and Scarci M. Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg 2011; 12: 1040-1045.
24. Roberts JR. Surgical treatment of mesothelioma: pleurectomy. Chest 1999; 116: 446S-9S.